Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  New Zealand Stock Exchange  >  Pacific Edge Limited    PEB   NZPEBE0002S1

PACIFIC EDGE LIMITED

(PEB)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote New Zealand Stock Exchang…
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
0.74 0.73 0.73 0.69 0.69 Last
1447074 632010 1420064 2598516 2752022 Volume
+4.23% -1.35% 0.00% -5.48% 0.00% Change
Financials
Sales 2021 10,6 M 7,44 M 7,44 M
Net income 2021 -9,57 M -6,72 M -6,72 M
Net cash position 2021 17,8 M 12,5 M 12,5 M
P/E ratio 2021 -51,5x
Yield 2021 -
Sales 2022 27,2 M 19,1 M 19,1 M
Net income 2022 6,86 M 4,82 M 4,82 M
Net cash position 2022 25,6 M 18,0 M 18,0 M
P/E ratio 2022 75,8x
Yield 2022 -
Capitalization 501 M 352 M 352 M
EV / Sales 2021 45,6x
EV / Sales 2022 17,5x
Nbr of Employees -
Free-Float 92,8%
More Financials
Company
Pacific Edge Limited is a cancer diagnostics company. The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. The Company's segments include NZ Laboratory, US Laboratory and Research NZ & Australia. Its segments are engaged in the research and development of diagnostic and prognostic products for human cancer both in New Zealand and Australia, and... 
More about the company
All news about PACIFIC EDGE LIMITED
11/02Australia shares make cautious gains ahead of U.S. election outcome
RE
10/12PACIFIC EDGE : Diagnostics Notified of CMS LCD Coverage for Cxbladder®
AQ
10/12Pacific Edge Diagnostics Notified of CMS LCD Coverage for Cxbladder®
GL
2019PACIFIC EDGE : US Clinical Review Reinforces Need for Cxbladder in Hematuria Gui..
PU
2019PACIFIC EDGE : Urologist KOL Profiles Cxbladder
PU
2019PACIFIC EDGE : Cxbladder Included in the Latest NCCN Bladder Cancer Guidelines i..
PU
2019PACIFIC EDGE : Request for Director Nominations
PU
2019PACIFIC EDGE : Cxbladder Adoption Roll-out Advances in New Zealand
PU
2018PACIFIC EDGE : Completes $7 Million Placement of New Shares
PU
2018PACIFIC EDGE : Announces Improved Result and Capital Raising
PU
2018PACIFIC EDGE : Full Suite of Cxbladder Tests Adopted by NZ Public Healthcare Pro..
PU
2018PACIFIC EDGE : Cxbladder Commercial Evaluation by Johns Hopkins Medicine
PU
2018PACIFIC EDGE : Receives Notification of Cxbladder National CMS Reimbursement Rat..
PU
2018PACIFIC EDGE : Another Of New Zealand's Public Healthcare Providers, Hauora Tair..
PU
2018PACIFIC EDGE : Another New Zealand Public Healthcare Provider Signs Up to Cxblad..
PU
More news
News in other languages on PACIFIC EDGE LIMITED

- No features available -

More news
Chart PACIFIC EDGE LIMITED
Duration : Period :
Pacific Edge Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PACIFIC EDGE LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 1
Average target price
Last Close Price 0,69 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
David Gregory Darling Chief Executive Officer, Executive Director & MD
Chris J. Gallaher Chairman
Jimmy Suttie Chief Operating Officer
Grant Gibson Chief Financial Officer
Parry Guilford Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC EDGE LIMITED475.00%350
LONZA GROUP AG55.15%44 901
MODERNA, INC.458.18%43 204
CELLTRION, INC.82.04%39 811
IQVIA HOLDINGS INC.9.94%32 568
SEAGEN INC.44.80%29 832